Sona Nanotech Secures Funding for Cancer Therapy Trials

Sona Nanotech Inc (TSE:SONA) has released an update.

Sona Nanotech Inc. has successfully completed a private placement, raising $1.5 million by issuing 6 million shares at $0.25 each to fund clinical trials for its cancer therapy technology and for general corporate purposes. Additionally, the company is planning to raise another $1.7 million through a similar private placement later in the month. Numus Capital Corp. acted as the finder for the deal, with compensation including cash and purchase warrants.

For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.